Patents by Inventor Jonathan Chestnut

Jonathan Chestnut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10745695
    Abstract: The invention generally relates to compositions and methods for designing and producing functional DNA binding effector molecules and associated customized services, tool kits and functional assays. In some aspects, the invention provides methods and tools for efficient assembly of customized TAL effector molecules. Furthermore, the invention relates to uses of TAL effector molecules and functional evaluation of such TAL by, for example, customized assays.
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: August 18, 2020
    Assignees: LIFE TECHNOLOGIES CORPORATION, THERMO FISHER SCIENTIFIC GENEART GMBH
    Inventors: Jonathan Chestnut, Matthias Arnold, Kevin Hoff
  • Publication number: 20190112596
    Abstract: The invention generally relates to compositions and methods for designing and producing functional DNA binding effector molecules and associated customized services, tool kits and functional assays. In some aspects, the invention provides methods and tools for efficient assembly of customized TAL effector molecules. Furthermore, the invention relates to uses of TAL effector molecules and functional evaluation of such TAL by, for example, customized assays.
    Type: Application
    Filed: April 12, 2018
    Publication date: April 18, 2019
    Inventors: Federico KATZEN, Jonathan CHESTNUT, Frank NOTKA, Matthias Arnold, Kevin HOFF, Stephen WHITESIDE
  • Publication number: 20050069929
    Abstract: The present invention is in the fields of biotechnology and molecular biology. More particularly, the present invention relates to cloning or subcloning one or more nucleic acid molecules comprising one or more type IIs restriction enzyme recognition sites. The present invention also embodies cloning such nucleic acid molecules using recombinational cloning methods such as those employing recombination sites and recombination proteins. The present invention also relates to nucleic acid molecules (including RNA and iRNA), as well as proteins, expressed from host cells produced using the methods of the present invention.
    Type: Application
    Filed: August 9, 2004
    Publication date: March 31, 2005
    Applicant: Invitrogen Corporation
    Inventors: Jonathan Chestnut, Knut Madden, Miroslav Dudas, Louis Leong, Adam Harris